PENICILLAMINE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for penicillamine and what is the scope of patent protection?

Penicillamine is the generic ingredient in four branded drugs marketed by Valeant Pharms Intl, Ani Pharms, Apotex, Breckenridge, Dr Reddys, Endo Operations, Granules, Invagen Pharms, Navinta Llc, Watson Labs Inc, Mylan Speciality Lp, Lupin Ltd, and Teva Pharms Usa, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for penicillamine. Fourteen suppliers are listed for this compound.

Summary for PENICILLAMINE

US Patents:	0
Tradenames:	4
Applicants:	13
NDAs:	14
Drug Master File Entries:	18
Finished Product Suppliers / Packagers:	14
Raw Ingredient (Bulk) Api Vendors:	105
Clinical Trials:	17
Patent Applications:	6,543
Drug Prices:	Drug price trends for PENICILLAMINE
What excipients (inactive ingredients) are in PENICILLAMINE?	PENICILLAMINE excipients list
DailyMed Link:	PENICILLAMINE at DailyMed

See drug prices for PENICILLAMINE

Recent Clinical Trials for PENICILLAMINE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Nanfang Hospital, Southern Medical University	Phase 2
Alexion Pharmaceuticals	Phase 2
Second Affiliated Hospital, School of Medicine, Zhejiang University	Early Phase 1

See all PENICILLAMINE clinical trials

Pharmacology for PENICILLAMINE

Drug Class	Antirheumatic Agent

Medical Subject Heading (MeSH) Categories for PENICILLAMINE

Antidotes
Antirheumatic Agents
Chelating Agents

Anatomical Therapeutic Chemical (ATC) Classes for PENICILLAMINE

M01CC	Penicillamine and similar agents
M01C	SPECIFIC ANTIRHEUMATIC AGENTS
M01	ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M	Musculo-skeletal system

US Patents and Regulatory Information for PENICILLAMINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lupin Ltd	PENICILLAMINE	penicillamine	TABLET;ORAL	212933-001	Nov 30, 2020	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Invagen Pharms	PENICILLAMINE	penicillamine	CAPSULE;ORAL	213293-001	Aug 19, 2021	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs Inc	PENICILLAMINE	penicillamine	CAPSULE;ORAL	210976-001	Jun 24, 2019	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.